首页>
外国专利>
USE OF EPIDERMAL GROWTH FACTOR IN THE MANUFACTURE OF A PHARMACEUTICAL INJECTION COMPOSITION FOR PREVENTING DIABETIC LIMB AMPUTATION
USE OF EPIDERMAL GROWTH FACTOR IN THE MANUFACTURE OF A PHARMACEUTICAL INJECTION COMPOSITION FOR PREVENTING DIABETIC LIMB AMPUTATION
展开▼
机译:表皮生长因子在制备预防糖尿病肢体的药物注射组合物中的应用
展开▼
页面导航
摘要
著录项
相似文献
摘要
A method comprising orally administering to a human or other mammal a pharmaceutical composition comprising from about 65% to about 110% of the cumulative effective dose of risedronate or a pharmaceutically acceptable acid, salt, ester, solvate, or polymorph thereof according to a continuous dosing schedule of one, two, or three consecutive days per month is useful for treating or preventing osteoporosis and other bone metabolic disorders.
展开▼